ask="32.50"
ask_size="100"
average_daily_volume="262033"
bid="25.00"
bid_size="100"
book_value="7.07"
change="-0.73"
change_from_200_day_moving_average="0.28"
change_from_50_day_moving_average="0.31"
change_from_52_week_high="-7.47"
change_From_52_week_low="16.45"
change_in_percent="-2.27%"
close="31.45"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.26"
ebitda="-177.88M"
eps_estimate_current_year="-4.40"
eps_estimate_next_quarter="-1.10"
eps_estimate_next_year="-4.07"
ex_dividend_date="N/A"
float_shares="28541000"
high="32.52"
high_52_weeks="38.92"
last_trade_date="3/2/2017"
last_trade_price="31.45"
last_trade_size="15452"
last_trade_time="4:00pm"
low="30.86"
low_52_weeks="15.00"
market_capitalization="1.56B"
moving_average_200_day="31.17"
moving_average_50_day="31.14"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.86"
open="31.91"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+0.88%"
percent_change_from_50_day_moving_average="+0.99%"
percent_change_from_52_week_high="-19.19%"
percent_change_from_52_week_low="+109.67%"
previous_close="32.18"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.55"
price_per_sales="32.79"
revenue="48.65M"
shares_outstanding="49569000"
short_ratio="19.05"
stock_exchange="NGM"
symbol="TBPH"
volume="322212"
weeks_range_52="15.00 - 38.92"
